NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 230 filers reported holding NOVOCURE LTD in Q3 2023. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| StepStone Group LP | 115,479 | $7,302,000 | 11.05% |
| HARTLINE INVESTMENT CORP/ | 335,585 | $21,219,000 | 5.07% |
| Darsana Capital Partners LP | 1,500,000 | $94,845,000 | 3.08% |
| Rhenman & Partners Asset Management AB | 365,899 | $23,136,000 | 2.55% |
| COURAGE CAPITAL MANAGEMENT LLC | 20,000 | $1,265,000 | 2.15% |
| Taylor Frigon Capital Management LLC | 46,599 | $2,946,000 | 2.04% |
| Granite Investment Partners, LLC | 411,659 | $26,029,000 | 1.40% |
| Nicholas Investment Partners, LP | 146,106 | $9,238,000 | 0.85% |
| Baillie Gifford | 8,829,449 | $558,287,000 | 0.59% |
| Cortina Asset Management, LLC | 141,352 | $8,938,000 | 0.55% |